Colgate Palmolive (CL) Cash & Equivalents (2009 - 2026)

Colgate Palmolive has reported Cash & Equivalents for 18 years, with the latest figure at $1.4 billion in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 12.76% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 12.76% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 17.52% from the prior year.
• Cash & Equivalents was $1.4 billion for Q2 2026 at Colgate Palmolive, up from $1.3 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $1.4 billion in Q2 2026, with the low at $775.0 million in Q4 2022.
• Average Cash & Equivalents over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents fell 11.86% in 2022, then soared 35.53% in 2024.
• Over 5 years, Cash & Equivalents stood at $775.0 million in 2022, then gained by 24.65% to $966.0 million in 2023, then increased by 13.46% to $1.1 billion in 2024, then increased by 17.52% to $1.3 billion in 2025, then climbed by 6.37% to $1.4 billion in 2026.
• The last three Cash & Equivalents figures came in at $1.4 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.